EcoDrugPlus

Monoamine Oxidase B

Ensembl ID : ENSCLAG00000000988
Gene Symbol: MAOB
2 Cross references
333 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSCLAG00000010527
Gene Symbol: MGLL
3 Cross references
209 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSCLAG00000005338
Gene Symbol: MLNR
2 Cross references
163 Possible Orthologues:

Multidrug Resistance Protein 1-Like

Ensembl ID : ENSCLAG00000001289
Gene Symbol: LOC102021022
1 Cross references
153 Possible Orthologues:

Multidrug Resistance Protein 1-Like

Ensembl ID : ENSCLAG00000004421
Gene Symbol: LOC102016302
1 Cross references
153 Possible Orthologues:

Myeloperoxidase

Ensembl ID : ENSCLAG00000015465
Gene Symbol: MPO
3 Cross references
182 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSCLAG00000004130
Gene Symbol: NPR1
2 Cross references
186 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSCLAG00000002859
Gene Symbol: NPR2
2 Cross references
260 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSCLAG00000008283
Gene Symbol: NPR3
2 Cross references
210 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSCLAG00000005000
Gene Symbol: NPY2R
3 Cross references
248 Possible Orthologues:

Neuropeptide Y Receptor Y4

Ensembl ID : ENSCLAG00000017395
Gene Symbol: NPY4R
2 Cross references
116 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSCLAG00000015988
Gene Symbol: NPY5R
3 Cross references
137 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).